Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Reproduction ; 158(5): 465-475, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31505459

RESUMEN

Fertilization failure often occurs during in vitro fertilization (IVF) cycles despite apparently normal sperm and oocytes. Accumulating evidence suggests that mitochondria play crucial roles in the regulation of sperm function and male fertility. 3-Nitrophthalic acid (3-NPA) can induce oxidative stress in mitochondria, and melatonin, as an antioxidant, can improve mitochondrial function by reducing mitochondrial oxidative stress. The role of sperm mitochondrial dysfunction in fertilization failure during IVF is unclear. The present study revealed that spermatozoa with low, or poor, fertilization rates had swollen mitochondria, increased mitochondria-derived ROS, and attenuated mitochondrial respiratory capacity. 3-NPA treatment enhanced mitochondrial dysfunction in sperm. Spermatozoa with poor fertilization rates, and spermatozoa treated with 3-NPA, had reduced penetration ability. The concentration of melatonin was decreased in semen samples with low and poor fertilization rates. Melatonin, not only decreased excessive mitochondria-derived ROS, but also 'rescued' the reduced penetration capacity of spermatozoa treated with 3-NPA. Taken together, the study suggested that mitochondria-derived ROS and mitochondrial respiratory capacity are independent bio-markers for sperm dysfunction, and melatonin may be useful in improving sperm quality and overall male fertility.


Asunto(s)
Fertilización/efectos de los fármacos , Melatonina/farmacología , Enfermedades Mitocondriales/patología , Interacciones Espermatozoide-Óvulo/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Espermatozoides/patología , Animales , Antioxidantes/metabolismo , Fenómenos Biomecánicos/efectos de los fármacos , Cricetinae , Femenino , Fertilización/fisiología , Fertilización In Vitro/métodos , Humanos , Infertilidad Masculina/etiología , Infertilidad Masculina/patología , Infertilidad Masculina/terapia , Masculino , Melatonina/uso terapéutico , Mitocondrias/efectos de los fármacos , Enfermedades Mitocondriales/fisiopatología , Enfermedades Mitocondriales/terapia , Oocitos/citología , Oocitos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Análisis de Semen , Espermatozoides/fisiología
2.
Zhonghua Nan Ke Xue ; 18(3): 253-6, 2012 Mar.
Artículo en Chino | MEDLINE | ID: mdl-22474993

RESUMEN

OBJECTIVE: To observe the pregnancy promoting effect of L-carnitine combined with intracytoplasmic sperm injection (ICSI) in treating male infertility with oligoasthenozoospermia. METHODS: We assigned 129 patients with oligoasthenozoospermia to receive 2 weeks of oral L-carnitine followed by ICSI (medication group, n = 42) and ICSI alone (control group, n = 87). We compared the sperm concentration and motility, the percentage of grade a + b sperm, and sperm deformity before and after L-carnitine medication, as well as the rates of fertilization, cleavage, available embryo and clinical pregnancy between the two groups. RESULTS: The percentage of grade a + b sperm was significantly increased after L-carnitine medication as compared with the baseline ([13.5 +/- 10.7] % vs [9.6 +/- 7.2] %, P<0.05), and so was the rate of available embryo in the medication group after ICSI in comparison with that of the control group (77.50% vs 69.04%, P<0.05). CONCLUSION: Short-term medication of L-carnitine can improve sperm quality and raise the success rate of ICSI.


Asunto(s)
Astenozoospermia/terapia , Carnitina/uso terapéutico , Oligospermia/terapia , Inyecciones de Esperma Intracitoplasmáticas/métodos , Adulto , Carnitina/administración & dosificación , Femenino , Humanos , Infertilidad Masculina/terapia , Masculino , Embarazo , Resultado del Embarazo
3.
Di Yi Jun Yi Da Xue Xue Bao ; 23(5): 510-1, 2003 May.
Artículo en Chino | MEDLINE | ID: mdl-12754150

RESUMEN

OBJECTIVE: To investigate the causes of urinary tract infections occurring in patients with indwelling urinary catheter, and to find the preventive means against this condition. METHODS: The clinical data of 152 such cases admitted between March, 2000 and February, 2002 in our department were reviewed. RESULTS: In this group of patients, 57 (37.5%) developed urinary infections due to the indwelling catheter, a rate significantly lower than that among previous cases (46.6%, P < 0.05) treated in our department. CONCLUSION: Careful evaluation of the indications for indwelling urinary catheter, strict aseptic procedures and shortened indwelling time of the catheter may help prevent the occurrence of the infection.


Asunto(s)
Catéteres de Permanencia/efectos adversos , Cateterismo Urinario/efectos adversos , Infecciones Urinarias/etiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Adhesión Bacteriana , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infecciones Urinarias/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA